CDMO
Discover MORPHO, full-service Pharma and Nutra CDMO
Morpho - Alfasigma's CDMO Business Unit
Morpho is a distinctive Contract Development and Manufacturing Organisation (CDMO), providing end-to-end pharmaceutical and nutraceutical solutions tailored to our partners' needs worldwide.
By combining technical excellence with a customer-centric approach, Morpho is dedicated to meeting the specific needs of its partners while shaping the future of pharmaceutical manufacturing.
Who We Are
Morpho is a multifaceted, full-service Pharma and Nutra CDMO committed to delivering high-quality solutions that support patients globally, driven by innovation, care, and excellence.
As part of Alfasigma, we ensure top-level quality through over 60 years of specialised expertise, staying true to our company values and leveraging innovative technologies.
We have a large production capacity, and we offer a remarkable versatility and diversification of products through a wide range of forms:
Liquid Injectables: Terminally sterilized & aseptic ampoules and vials, pre-filled syringes, and cartridges.
Sterile Powders and Lyophilised Products in vials and ampoules
Vaccines and Sterile Hormonal Products
Semi solids and liquids topical (gel & creams, enemas)
Semi solids and liquids oral (syrups, emulsions, suspensions, softgels)
Pressurized foams and oral solids (tablets, capsules, sachets, granules in sachets, stick pack)
Additionally, we invest in advanced formulation and manufacturing technologies, including freeze-drying and proprietary IP-protected processes.
Why Choose Morpho?
Our approach is built on partnership, reliability, and flexibility.
We seek to collaborate with companies interested in building long term partnerships, including biotech and startups, as well as mid-sized and large pharmaceutical companies looking for a CDMO capable to act on quick preformulating for rapid screening up to large commercial scale.
Comprehensive Manufacturing Network
Morpho’s manufacturing network spans strategic locations across Europe and the US, offering specialised capabilities that cater to diverse pharmaceutical needs:
Italy Operations
Alanno (Pescara): A centre of excellence for sterile manufacturing, equipped with state-of-the-art facilities for injectable products and vaccines
- Ampoules
- Vials
*Including corticosteroids & sexual hormones
- Sterile powder vials filling
- Small volume liquids ampoules (terminally sterilised & aseptic process)
- Small volume liquids vials (terminally sterilised & aseptic process)
- Prefilled syringes and cartridges** (terminally sterilised & aseptic process)
*Including corticosteroids & sexual hormones
**Including vaccines
Pomezia (Rome): Specialising in oral solid dose forms with integrated R&D capabilities
- Tablets* (incl. film coated)
- Capsules
- Sachets
*Including corticosteroids & sexual hormones
- Soft Gels
- Suppositories
- Syrups
Sermoneta (Latina): Advanced manufacturing facility (Biosint, Alfasigma Group), with particular expertise in carnitine chemistry, salts and derivatives, both as APIs and nutraceutical ingredients, in compliance with GMPs standards.
Our carnitines are Halal, Kosher, ISO 9001 certified and they are approved administered worldwide (such as Italian AIFA, US FDA and Japanese PMDA).
Nutraceutical applications for our carnitines, include: newborn formula, sport management, weight reduction programs, general wellbeing, fitness and physical maintenance, mental performance, anti-stress solutions and more.
Click here to see our list of nutraceutical ingredients.
Trezzano Rosa (Milan Area): Multi-purpose facility handling solid dosage forms, enemas, liquids, and creams
- Tablets* (incl. film coated)
- Granules in sachets
*Including corticosteroids & sexual hormones
- Creams & gels
- Enemas
- Emulsions
- Suspensions
- Foams*
*Including corticosteroids & sexual hormones
US Operations
Shreveport (Louisiana): Dedicated nutraceutical production facility
- Tablets
- Capsules
- Stick pack
Italy Pharmaceutical Development Centre
Pomezia (Rome): Labio 4.0 Marino Golinelli is constituted by pharmaceutical technology and analytical laboratories and an oral solid pilot plant.
- Product development Scale-up
- Scale-down for troubleshooting, problem solving, process optimization
- Production for Clinical Trials (Phases I, II & III)
- Small batch size commercial production
*The pilot plant and AD/QC labs received the AIFA GMP certification for production and release of oral solid forms
- Analytical method development & validation
- Impurities characterisation
- Release analysis & certification
- Stability studies
*The pilot plant and AD/QC labs received the AIFA GMP certification for production and release of oral solid forms
- Product development at Lab-scales & Kilolab
- DoEs for troubleshooting, problem solving, process optimisation
- Solid state characterisation
- New formulations development
The Meaning Behind Morpho: Shaping the Future of Pharmaceutical Innovation
“Morpho” comes from ancient Greek, meaning "to form, to shape," symbolizing a process of continuous creation and transformation. This reflects Morpho's ability to create custom pharmaceutical solutions for its clients.
If you want more information please contact the Morpho - CDMO Office: [email protected]